Melanoma migration is promoted by prion protein via Akt-hsp27 signaling axis

Jingru Ke1, Guiru Wu2, Jie Zhang3

  • 1Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, State Key Laboratory of Respiratory Diseases, 78 Hengzhigang Road, Guangzhou, 510095, China.

Insights

Prion protein (PrP) significantly reduces melanoma cell migration by modulating the Akt-hsp27-F-actin pathway, independent of filamin A. This finding offers new insights into metastatic melanoma progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Metastatic melanoma presents a significant clinical challenge with poor patient prognosis.
  • Prion protein (PrP) is implicated in melanoma cell migration and invasion, partly through interaction with filamin A (FLNa).

Purpose of the Study:

  • To investigate the role of PrP in melanoma cell mobility independently of its interaction with FLNa.
  • To elucidate the molecular mechanisms by which PrP influences cell migration.

Main Methods:

  • Utilized CRISPR-Cas9 to knock out the PRNP gene in M2 melanoma cells, which naturally lack FLNa expression.
  • Assessed cell motility, protein expression levels (Akt, phosphorylated hsp27), and F-actin polymerization.
  • Re-expressed PrP in PRNP-null cells to confirm findings.

Main Results:

  • PRNP deletion significantly reduced M2 melanoma cell motility.
  • PrP deficiency led to decreased Akt levels and reduced phosphorylation of small heat shock protein (hsp27).
  • This resulted in altered F-actin polymerization, hindering cell migration.

Conclusions:

  • Prion protein (PrP) plays a crucial role in cytoskeletal organization and tumor cell migration in melanoma, independent of FLNa.
  • PrP modulates cell motility through the Akt-hsp27-F-actin signaling axis.
  • Targeting PrP may offer a therapeutic strategy for metastatic melanoma.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K